share_log

复星医药(02196.HK)将于8月29日举行董事会会议以审批中期业绩

Shanghai Fosun Pharmaceutical (02196.HK) will hold a board meeting on August 29th to approve interim results

Gelonghui Finance ·  Aug 15, 2022 17:10

Shanghai Fosun Pharmaceutical (02196.HK) announced that the company will hold a board meeting on August 29th, 2022 to consider and approve the interim results and announcements of the company and its subsidiaries for the six months ended June 30th, 2022.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment